Wordt geladen...
Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy. Comment on Strobel et al., Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 2019, 7, 69
Temozolomide, a DNA methylating drug, is currently being used first-line in glioblastoma therapy. Although the mode of action of this so-called S(N)1 alkylating agent is well described, including the types of induced DNA damage triggering the DNA damage response and survival and death pathways, some...
Bewaard in:
| Gepubliceerd in: | Biomedicines |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966492/ https://ncbi.nlm.nih.gov/pubmed/31717973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines7040090 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|